Evidence map›Paper›PMID 25357095›Full record

ReviewJournal of perinatology : official journal of the California Perinatal Association2015

Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity.

W S Harris, M L Baack

Open access · greenAbstract readReview
In one paragraph

Review in Journal of perinatology : official journal of the California Perinatal Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Preterm nutrition and neurodevelopmental outcomes.World journal of methodology · 2021
    Review
  17. Article
  18. PlacentalMolecular medicine (Cambridge, Mass.) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

W S Harris1] Sanford School of Medicine-University of South Dakota, Department of Internal Medicine, SD, USA [2] OmegaQuant, LLC, Sioux Falls, SD, USA [3] Health Diagnostics Laboratory Inc, SD, USA [4] Sanford Health Research Center, Sioux Falls, SD, USA.
M L Baack1] Sanford School of Medicine-University of South Dakota, Neonatal-Perinatal Medicine, Department of Pediatrics, Sioux Falls, SD, USA [2] Sanford Children's Health Research Center, Sioux Falls, SD, USA.
University of South Dakota · US

Funding

Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
Lipotoxic Effects of Maternal Diabetes and High Fat Diet on the Developing HeartK08HD078504 · NICHD · SANFORD RESEARCH/USD · PI BAACK, MICHELLE LEIGH · 2014 to 2018
$599k
NICHD NIH HHS 1K08HD078504NICHD NIH HHS K08 HD078504NIGMS NIH HHS P20 GM103620NIGMS NIH HHS P20 GM103620-01A1
6 · The paper itself

Abstract

Long-chain polyunsaturated fatty acids (LCPUFA) including docosahexaenoic acid (DHA) are essential for normal vision and neurodevelopment. DHA accretion in utero occurs primarily in the last trimester of pregnancy to support rapid growth and brain development. Premature infants, born before this process is complete, are relatively deficient in this essential fatty acid. Very low birth weight (VLBW) infants remain deficient for a long period of time due to ineffective conversion from precursor fatty acids, lower fat stores and a limited nutritional provision of DHA after birth. In addition to long-term visual and neurodevelopmental risks, VLBW infants have significant morbidity and mortality from diseases specific to premature birth, including bronchopulmonary dysplasia, necrotizing enterocolitis, and retinopathy of prematurity. There is increasing evidence that DHA has protective benefits against these disease states. The aim of this article is to identify the unique needs of premature infants, review the current recommendations for LCPUFA provision in infants and discuss the caveats and innovative new ways to overcome the DHA deficiency through postnatal supplementation, with the long-term goal of improving morbidity and mortality in this at-risk population.

Indexed as

BrainDocosahexaenoic AcidsFatty Acids, UnsaturatedHumansInfant, NewbornInfant, PrematureInfant, Premature, DiseasesNervous SystemNutritional RequirementsVision, OcularDocosahexaenoic AcidsFatty Acids, Unsaturated

Identifiers

PMID25357095
PMCPMC4281288
OpenAlexW2092468199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.